These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27539610)

  • 1. A meta-analysis of the effect of different neuroprotective drugs in management of patients with traumatic brain injury.
    El Sayed I; Zaki A; Fayed AM; Shehata GM; Abdelmonem S
    Neurosurg Rev; 2018 Apr; 41(2):427-438. PubMed ID: 27539610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
    Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS
    JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cerebrolysin on functional recovery in patients with severe disability after traumatic brain injury: A historical cohort study.
    Khalili H; Niakan A; Ghaffarpasand F
    Clin Neurol Neurosurg; 2017 Jan; 152():34-38. PubMed ID: 27871029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study.
    Chen CC; Wei ST; Tsaia SC; Chen XX; Cho DY
    Br J Neurosurg; 2013 Dec; 27(6):803-7. PubMed ID: 23656173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of cerebrolysin in neurorecovery after moderate-severe traumatic brain injury: results from the CAPTAIN II trial.
    Muresanu DF; Florian S; Hömberg V; Matula C; von Steinbüchel N; Vos PE; von Wild K; Birle C; Muresanu I; Slavoaca D; Rosu OV; Strilciuc S; Vester J
    Neurol Sci; 2020 May; 41(5):1171-1181. PubMed ID: 31897941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery Trajectories and Long-Term Outcomes in Traumatic Brain Injury: A Secondary Analysis of the Phase 3 Citicoline Brain Injury Treatment Clinical Trial.
    Puffer RC; Yue JK; Mesley M; Billigen JB; Sharpless J; Fetzick AL; Puccio AM; Diaz-Arrastia R; Okonkwo DO
    World Neurosurg; 2019 May; 125():e909-e915. PubMed ID: 30763755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monitoring of neurotrophic factors and cognitive function in patients with traumatic brain injury].
    Karakulova YV; Selyanina NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):34-37. PubMed ID: 29171486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Traumatic Coagulopathy Accompanying Isolated Traumatic Brain Injury is Associated with Worse Long-Term Functional and Cognitive Outcomes.
    Abdelmalik PA; Boorman DW; Tracy J; Jallo J; Rincon F
    Neurocrit Care; 2016 Jun; 24(3):361-70. PubMed ID: 26293923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citicoline on the Barthel Index: Severe and moderate brain injury.
    Mahmoodkhani M; Aminmansour B; Shafiei M; Hasas M; Tehrani DS
    Indian J Pharmacol; 2023; 55(4):223-228. PubMed ID: 37737074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of cerebrolysin on moderate and severe head injury patients: result of a cohort study.
    Wong GK; Zhu XL; Poon WS
    Acta Neurochir Suppl; 2005; 95():59-60. PubMed ID: 16463821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citicoline in severe traumatic brain injury: indications for improved outcome : A retrospective matched pair analysis from 14 Austrian trauma centers.
    Trimmel H; Majdan M; Wodak A; Herzer G; Csomor D; Brazinova A
    Wien Klin Wochenschr; 2018 Jan; 130(1-2):37-44. PubMed ID: 28752349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cerebrolysin in the treatment of brain injuries of moderate severity].
    Talypov AE; Myachin MY; Kuksova NS; Kordonsky AY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(11):98-106. PubMed ID: 25591645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with citicoline may improve poststroke vascular cognitive impairment.
    Alvarez-Sabín J; Ortega G; Jacas C; Santamarina E; Maisterra O; Ribo M; Molina C; Quintana M; Román GC
    Cerebrovasc Dis; 2013; 35(2):146-54. PubMed ID: 23406981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citicoline: pharmacological and clinical review, 2006 update.
    Secades JJ; Lorenzo JL
    Methods Find Exp Clin Pharmacol; 2006 Sep; 28 Suppl B():1-56. PubMed ID: 17171187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrolysin after moderate to severe traumatic brain injury: prospective meta-analysis of the CAPTAIN trial series.
    Vester JC; Buzoianu AD; Florian SI; Hömberg V; Kim SH; Lee TMC; Matula C; Poon WS; Sandesc D; von Steinbüchel N; Strilciuc S; Vos PE; von Wild K; Muresanu D
    Neurol Sci; 2021 Nov; 42(11):4531-4541. PubMed ID: 33620612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective, multi-center cohort study evaluating the severity- related effects of cerebrolysin treatment on clinical outcomes in traumatic brain injury.
    Muresanu DF; Ciurea AV; Gorgan RM; Gheorghita E; Florian SI; Stan H; Blaga A; Ianovici N; Iencean SM; Turliuc D; Davidescu HB; Mihalache C; Brehar FM; Mihaescu AS; Mardare DC; Anghelescu A; Chiparus C; Lapadat M; Pruna V; Mohan D; Costea C; Costea D; Palade C; Bucur N; Figueroa J; Alvarez A
    CNS Neurol Disord Drug Targets; 2015; 14(5):587-99. PubMed ID: 25924999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is aura around citicoline fading? A systemic review.
    Agarwal S; Patel BM
    Indian J Pharmacol; 2017; 49(1):4-9. PubMed ID: 28458415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of neurotrophic treatment on the activation of reparative processes in patients with acute traumatic brain injury].
    Selianina NV; Karakulova IuV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5):46-9. PubMed ID: 22951781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparative study of noopept and piracetam in the treatment of mild and moderate cognitive impairment in patients with organic brain diseases of vascular and traumatic origin].
    Neznamov GG; Teleshova ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(3):33-42. PubMed ID: 18697252
    [No Abstract]   [Full Text] [Related]  

  • 20. [Electrophysiological correlates of efficacy of nootropic drugs in the treatment of consequences of traumatic brain injury in adolescents].
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Suppl 1):27-32. PubMed ID: 20559264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.